Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Contemp Clin Trials. 2019 Oct 13;86:105852. doi: 10.1016/j.cct.2019.105852

Figure 1.

Figure 1.

Plot of sensitivity analyses for the serious adverse event (SAE) rate (left panel) and variability of site effect (right panel) when the difference of FCASS measured between corticosteroids and control was −1.6 (i.e., the fourth scenario).